Literature DB >> 10634001

Prevalence of factor V Leiden in the Chinese population.

C H Ho1, W K Chau, H C Hsu, J P Gau, C M Chih.   

Abstract

BACKGROUND: Thromboembolic diseases remain a major cause of morbidity and mortality in most countries. Factor V Leiden was found to be a major cause of thromboembolic disease in Western countries. Chinese have proved to be less prone to thromboembolic diseases, therefore investigation of the prevalence of factor V Leiden is necessary among a Chinese population.
METHODS: From May, 1997, to April, 1998, a total of 1,261 subjects, including 420 healthy subjects, 719 patients with nonthrombotic hematologic disorders, 77 patients with diabetes mellitus and 45 patients with deep vein thrombosis, different in age and sex, were consecutively entered into our study to determine the prevalence of factor V Leiden in the Chinese population (mean age, 50.1 +/- 18.3 years; range, 1-99 years). Of this population, 873 were male and 388 were female.
RESULTS: None of the subjects was found to have factor V Leiden mutation (Arg 506-Gln mutation). Activated protein C resistance was also measured in 827 patients; none of them had an activated protein C ratio of less than 2.0.
CONCLUSIONS: We suggest that factor V Leiden mutation is rare among the Chinese.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10634001

Source DB:  PubMed          Journal:  Zhonghua Yi Xue Za Zhi (Taipei)        ISSN: 0578-1337


  8 in total

1.  Low protein Z plasma level is a risk factor for acute myocardial infarction in coronary atherosclerosis disease patients.

Authors:  Baoxin Liu; Yong Li; Jiachen Luo; Liming Dai; Jinlong Zhao; Hongqiang Li; Qiqiang Jie; Dongzhi Wang; Xin Huang; Yidong Wei
Journal:  Thromb Res       Date:  2016-10-13       Impact factor: 3.944

2.  Race differences in the prevalence of the factor V Leiden mutation in Kuwaiti nationals.

Authors:  Ali A Dashti; Mehrez M Jadaon
Journal:  Mol Biol Rep       Date:  2010-11-21       Impact factor: 2.316

3.  Clinical Manifestations and Prognostic Factors of Pulmonary Embolism in Adult Patients Visiting the Emergency Department: A Single Institute Experience.

Authors:  Hung-Chun Chung; Ching-Ching Lee; Yu-Hua Lin
Journal:  J Acute Med       Date:  2019-03-01

4.  Prevalence of resistence to activated protein C (APC-resistance) in blood donors in Kosovo.

Authors:  Ymer Mekaj; Bukurije Zhubi; Hakif Hoxha; Remzije Belegu; Agon Mekaj; Ermira Miftari; Mazllum Belegu
Journal:  Bosn J Basic Med Sci       Date:  2009-11       Impact factor: 3.363

5.  Risk factors of venous thromboembolism in thai patients.

Authors:  Pantep Angchaisuksiri; Vichai Atichartakarn; Katcharin Aryurachai; Napaporn Archararit; Buppa Rachakom; Kanlayanee Atamasirikul; Arjit Tiraganjana
Journal:  Int J Hematol       Date:  2007-12       Impact factor: 2.490

6.  Epidemiology of activated protein C resistance and factor v leiden mutation in the mediterranean region.

Authors:  Mehrez M Jadaon
Journal:  Mediterr J Hematol Infect Dis       Date:  2011-09-08       Impact factor: 2.576

7.  Dialysis catheter-related pulmonary embolism in a patient with paraquat intoxication.

Authors:  Li-Keng Chao; Te-Chao Fang
Journal:  Ci Ji Yi Xue Za Zhi       Date:  2015-07-02

8.  The prevalence of Factor V Leiden (Arg506Gln) mutation in King Khalid University Hospital patients, 2017-2019.

Authors:  Maram Al-Otaiby; Rahaf Althnayan; Alanoud Binmethem; Reema Bader AlEnezy; Munira Abdulrahman Alhadlg; Arjuwana Alaqeel; Sara H AlQahtani; Noman Ghufran; Abdulaziz A Alotaibi; Nada Alayed; Imran Ali Khan
Journal:  Nagoya J Med Sci       Date:  2021-08       Impact factor: 1.131

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.